Search

Author/Creator Neuvonen, Mikko

1. A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics. Issue 1 (22nd August 2022)

Authors:
Lehtisalo, Minna; Taskinen, Suvi; Tarkiainen, E. Katriina; Neuvonen, Mikko; Viinamäki, Jenni; Paile‐Hyvärinen, Maria; Lilius, Tuomas O.; Tapaninen, Tuija; Backman, Janne T.; Tornio, Aleksi; Niemi, Mikko
Journal:
British journal of clinical pharmacology
Issue:
Volume 89:Issue 1(2023)
Page Start:
242
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A3 - A High-throughput double cocktail approach for evaluating time-dependent inhibition of nine major human cytochrome P450 enzymes. (2020)

Authors:
Kahma, Helinä; Aurinsalo, Laura; Neuvonen, Mikko; Viinamäki, Jenni; Launiainen, Terhi; Filppula, Anne M.; Tornio, Aleksi; Backman, Janne T.
Journal:
Drug metabolism and pharmacokinetics
Issue:
Volume 35(2020)Supplement 1
Page Start:
S19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel. Issue 1 (9th August 2018)

Authors:
Itkonen, Matti K.; Tornio, Aleksi; Lapatto‐Reiniluoto, Outi; Neuvonen, Mikko; Neuvonen, Pertti J.; Niemi, Mikko; Backman, Janne T.
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 105:Issue 1(2019)
Page Start:
219
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics. Issue 1 (6th November 2017)

Authors:
Hirvensalo, Päivi; Tornio, Aleksi; Neuvonen, Mikko; Tapaninen, Tuija; Paile‐Hyvärinen, Maria; Kärjä, Vesa; Männistö, Ville T.; Pihlajamäki, Jussi; Backman, Janne T.; Niemi, Mikko
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 104:Issue 1(2018)
Page Start:
158
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. CYP3A4*22 Impairs the Elimination of Ticagrelor, But Has No Significant Effect on the Bioactivation of Clopidogrel or Prasugrel. Issue 2 (20th August 2018)

Authors:
Holmberg, Mikko T.; Tornio, Aleksi; Paile‐Hyvärinen, Maria; Tarkiainen, E. Katriina; Neuvonen, Mikko; Neuvonen, Pertti J.; Backman, Janne T.; Niemi, Mikko
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 105:Issue 2(2019)
Page Start:
448
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Effects of carboxylesterase 1 single nucleotide variations on the pharmacokinetics and pharmacydynamics of clopidogrel. Issue 1 (January 2017)

Authors:
Katriina Tarkiainen, E.; Neuvonen, Mikko; Tornio, Aleksi; Holmberg, Mikko T.; Itkonen, Matti; Neuvonen, Pertti J.; Backman, Janne T.; Niemi, Mikko
Journal:
Drug metabolism and pharmacokinetics
Issue:
Volume 32:Issue 1(2017)Supplement
Page Start:
S111
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Effects of Genetic Variants on Carboxylesterase 1 Gene Expression, and Clopidogrel Pharmacokinetics and Antiplatelet Effects. Issue 3 (17th November 2017)

Authors:
Neuvonen, Mikko; Tarkiainen, E. Katriina; Tornio, Aleksi; Hirvensalo, Päivi; Tapaninen, Tuija; Paile‐Hyvärinen, Maria; Itkonen, Matti K.; Holmberg, Mikko T.; Kärjä, Vesa; Männistö, Ville T.; Neuvonen, Pertti J.; Pihlajamäki, Jussi; Backman, Janne T.; Niemi, Mikko
Journal:
Basic & clinical pharmacology & toxicology
Issue:
Volume 122:Issue 3(2018)
Page Start:
341
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗